S18 New Insights in Gonadotrope Biology

Program: Symposia
Basic Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
Room 160 (BCEC)
Daniel J. Bernard, PhD, McGill University, Montreal, Canada

Nothing to Disclose: DJB Disclosure Not Provided: VGT
4:45 PM
Mark A Lawson, PhD, Reproductive Medicine, University of California-San Diego, La Jolla, CA
Nothing to Disclose: MAL
5:15 PM
Stuart C. Sealfon, MD, Neurology Department and Center for Translational Systems Biology, Icahn School of Medicine at Mount Sinai, New York, NY
Nothing to Disclose: SCS
5:45 PM
Gwen V. Childs, PhD, Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR
Nothing to Disclose: GVC
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire